Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries-A Commentary
JCO Glob Oncol
.
2021 Jul:7:1194-1198.
doi: 10.1200/GO.21.00195.
Authors
Murallitharan Munisamy
1
2
,
Kingsley Ndoh
2
3
,
Ahmed Abdelbadee
2
4
,
Isthar Espejo
2
5
,
Florence Manjuh
2
6
,
Alexandra Tamas
2
7
,
Omolola Salako
2
8
9
10
,
Felipe Roitberg
2
11
12
Affiliations
1
National Cancer Society of Malaysia, Kuala Lumpur, Malaysia.
2
Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.
3
Department of Global Health, University of Washington, Seattle, WA.
4
Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt.
5
Fundacion Aladina, Madrid, Spain.
6
Women's Health Program, Cameroon Baptist Convention Health Services, Cameroon.
7
European Network for Smoking and Tobacco Prevention.
8
Department of Radiation Biology, Radiotherapy and Radiodiagnosis, College of Medicine, University of Lagos, Nigeria.
9
Sebeccly Cancer Care, Lagos, Nigeria.
10
Oncopadi Digital Clinic, Lagos, Nigeria.
11
Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil.
12
European Society for Medical Oncology (ESMO), Lugano, Switzerland.
PMID:
34292779
PMCID:
PMC8457777
DOI:
10.1200/GO.21.00195
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19*
Developing Countries
Humans
Neoplasms*
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines